Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) soared Tuesday in reaction to Roche Holdings AG‘s (OTC:RHHBY) phase 3 results from the lidERA Breast Cancer study of giredestrant in early-stage breast cancer."Pharma Bro” and notorious bear Martin Shkreli is shorting Olema stock. OLMA stock is racing higher. See the real-time price action here. Shkreli publicly declared his short position in a social media post on Tuesday morning. Read Next: Ready For A Rebound? Here Are 10 Oversold Stocks To Watch "Short ...